openPR Logo
Press release

Achromatopsia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Applied Genetic Technologies Crp, MeiraGTx and Janssen Pharmaceuticals

05-21-2024 09:13 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Achromatopsia Market Report 2032: Epidemiology Data, Pipeline

DelveInsight's "Achromatopsia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Achromatopsia, historical and forecasted epidemiology as well as the Achromatopsia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Achromatopsia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Achromatopsia Market Forecast
https://www.delveinsight.com/sample-request/achromatopsia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Achromatopsia Market Report:
• The Achromatopsia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• According to Michalakis et al. 2021, one in 30,000 people are affected with the rare hereditary eye illness achromatopsia (ACHM), which is inherited in an autosomal recessive manner
• Key Achromatopsia Companies: Applied Genetic Technologies Crp, MeiraGTx and Janssen Pharmaceuticals, and others
• Key Achromatopsia Therapies: AGTC-401 and AGTC-402, AAV CNGA3 And AAV-CNGB3, and others
• The Achromatopsia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Achromatopsia pipeline products will significantly revolutionize the Achromatopsia market dynamics.

Achromatopsia Overview
The cones of the retina are impacted by the autosomal recessively inherited retinal condition known as achromatopsia, sometimes referred to as rod monochromatism or total colour blindness. Patients frequently express frustration that certain colours seem black and white, washed out, grey, or unclean.

Get a Free sample for the Achromatopsia Market Report:
https://www.delveinsight.com/report-store/achromatopsia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Achromatopsia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Achromatopsia Epidemiology Segmentation:
The Achromatopsia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Achromatopsia
• Prevalent Cases of Achromatopsia by severity
• Gender-specific Prevalence of Achromatopsia
• Diagnosed Cases of Episodic and Chronic Achromatopsia

Download the report to understand which factors are driving Achromatopsia epidemiology trends @ Achromatopsia Epidemiology Forecast
https://www.delveinsight.com/sample-request/achromatopsia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Achromatopsia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Achromatopsia market or expected to get launched during the study period. The analysis covers Achromatopsia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Achromatopsia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Achromatopsia Therapies and Key Companies
• AGTC-401 and AGTC-402: Applied Genetic Technologies Crp.
• AAV CNGA3 And AAV-CNGB3: MeiraGTx and Janssen Pharmaceuticals

Discover more about therapies set to grab major Achromatopsia market share @ Achromatopsia Treatment Market
https://www.delveinsight.com/sample-request/achromatopsia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Achromatopsia Market Strengths
• Positive results of emerging gene therapies promises the potential treatment options for achromats in coming years

Achromatopsia Market Opportunities
• The growing investments by public, governmental and private bodies for research on diseases and special designation from the regulatory authorities will provide potential opportunities for the growth of the achromatopsia treatment market in the coming years

Scope of the Achromatopsia Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Achromatopsia Companies: Applied Genetic Technologies Crp, MeiraGTx and Janssen Pharmaceuticals, and others
• Key Achromatopsia Therapies: AGTC-401 and AGTC-402, AAV CNGA3 And AAV-CNGB3, and others
• Achromatopsia Therapeutic Assessment: Achromatopsia current marketed and Achromatopsia emerging therapies
• Achromatopsia Market Dynamics: Achromatopsia market drivers and Achromatopsia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Achromatopsia Unmet Needs, KOL's views, Analyst's views, Achromatopsia Market Access and Reimbursement

To know more about Achromatopsia companies working in the treatment market, visit @ Achromatopsia Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/achromatopsia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Achromatopsia Market Report Introduction
2. Executive Summary for Achromatopsia
3. SWOT analysis of Achromatopsia
4. Achromatopsia Patient Share (%) Overview at a Glance
5. Achromatopsia Market Overview at a Glance
6. Achromatopsia Disease Background and Overview
7. Achromatopsia Epidemiology and Patient Population
8. Country-Specific Patient Population of Achromatopsia
9. Achromatopsia Current Treatment and Medical Practices
10. Achromatopsia Unmet Needs
11. Achromatopsia Emerging Therapies
12. Achromatopsia Market Outlook
13. Country-Wise Achromatopsia Market Analysis (2019-2032)
14. Achromatopsia Market Access and Reimbursement of Therapies
15. Achromatopsia Market Drivers
16. Achromatopsia Market Barriers
17. Achromatopsia Appendix
18. Achromatopsia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Achromatopsia Pipeline https://www.delveinsight.com/report-store/achromatopsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Achromatopsia Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Achromatopsia market. A detailed picture of the Achromatopsia pipeline landscape is provided, which includes the disease overview and Achromatopsia treatment guidelines.

Latest Report Offered By DelveInsight:

Surgical Robotic System Market https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical Robotic Systems Market By Application (Urology, Gynecology, Neurosurgery, Orthopedics, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), And by geography is estimated to register appreciable CAGR forecast till 2028 owing to increase in surgical procedures and rising popularity of minimally invasive surgical interventions.

Cancer Diagnostics Market
https://www.delveinsight.com/report-store/cancer-diagnostic-market
Cancer Diagnostics Market By Type (Product Type [Reagent & Kits and Instruments], and Services), Technique (Molecular Diagnostics [Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescent In-Situ Hybridization (FISH), Microarray, and Immunohistochemistry], Diagnostics Imaging [Ultrasound & Radiology, Mammography, MRI Scan, CT Scan, and Nuclear Medicine Scans], Endoscopy, and Biopsy [Standard Biopsy and Liquid Biopsy]), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Others), End-User (Hospitals, Diagnostics Labs, and Others), and Geography, is expected to grow at a significant CAGR forecast till 2028 owing to the growing burden of cancer across the globe and rise in various product launches for efficient detection of cancer.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to lauch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Achromatopsia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Applied Genetic Technologies Crp, MeiraGTx and Janssen Pharmaceuticals here

News-ID: 3506782 • Views:

More Releases from DelveInsight Business Research

Breast Cancer Biomarker Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight | Pfizer, AstraZeneca, Sermonix Pharmaceuticals, Novartis
Breast Cancer Biomarker Market Forecast 2032: FDA, EMA and PDMA Approvals, Epide …
(Albany, USA) DelveInsight's "Breast Cancer Biomarker Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Breast Cancer Biomarker, historical and forecasted epidemiology as well as the Breast Cancer Biomarker market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Breast Cancer Biomarker market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and
Murine Double Minute 2 (MDM2) Inhibitor Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight
Murine Double Minute 2 (MDM2) Inhibitor Pipeline Analysis 2024: FDA Approvals, C …
(Albany, USA) As per DelveInsight's assessment, globally, Murine Double Minute 2 (MDM2) Inhibitor pipeline constitutes key companies continuously working towards developing Murine Double Minute 2 (MDM2) Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Murine Double Minute 2 (MDM2) Inhibitor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Murine
Interstitial Lung Disease Clinical Trials Analysis 2024: FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight
Interstitial Lung Disease Clinical Trials Analysis 2024: FDA Approvals, Pipeline …
(Albany, United States) As per DelveInsight's assessment, globally, Interstitial Lung Disease pipeline constitutes 120+ key companies continuously working towards developing 120+ Interstitial Lung Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Interstitial Lung Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Interstitial Lung Disease Market. The Interstitial Lung Disease
Myopia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and companies by DelveInsight | Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics
Myopia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechan …
(Albany, USA) As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 10+ pipeline drugs in the Myopia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Myopia Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis

All 5 Releases


More Releases for Achromatopsia

Achromatopsia Treatment Market Size, Growth, Demand, Development, Market Scope, …
The Achromatopsia Treatment Market report provides details on market share, new developments, and product portfolio analysis, impact of national and localized market players, pocket opportunity analysis, emerging revenue streams , changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technology. innovations in the market. To understand Color Blind Treatment market scenario and analysis, please contact Data Bridge Market Research for analyst summary. Our
Achromatopsia Treatment Market Research Analysis, Regional Analysis, Global Indu …
The achromatopsia treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the achromatopsia treatment market scenario, contact Data bridge market research for an Analyst Brief, Our
Achromatopsia Treatment Market 2020-2027 is Dazzling Worldwide. Detailed Profile …
With the nice combination of hard work of skilled forecasters, well-versed analysts and knowledgeable researchers, such premium outcome, in the form of Achromatopsia Treatment market research report can be attained. By clearly identifying and analysing the emerging trends in the market, this market report also explains major drivers, challenges and opportunities in the market for Healthcare industry. The report endows with the wide-ranging statistical analysis of the market's constant developments,
Global Inherited Retinal Diseases Market Current Trends and Technology Enhanceme …
Inherited retinal diseases market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to an annual growth rate of 4.40% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits associated with the usage of inherited retinal diseases has been directly impacting the growth of inherited retinal diseases market. This Inherited
Achromatopsia Treatment Market 2020-2027 Current Trends and Future Aspect Analys …
For producing such excellent Achromatopsia Treatment market research report, principal attributes such as highest level of spirit, practical solutions, dedicated research and analysis, innovation, talent solutions, integrated approaches, most advanced technology and commitment plays a key role. Global Achromatopsia Treatment market report provides in-depth market data and forecast by analyzing key business trends and identifying potential growth avenues across the entire value chain. According to this business research report, new
Achromatopsia Treatment Market 2020 Global Trends Analysis || Leading Players - …
Achromatopsia treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a substantial CAGR in the above-mentioned research forecast period. Increasing investments by various governments in R&D related to genomics increasing investment in research and development and growth in biotechnology sector are the factors responsible for the growth of this market Get Exclusive Sample Copy